Myomo (MYO) Gross Profit (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.45% |
| Jun 30, 2025 | -8.43% |
| Mar 31, 2025 | -23.28% |
| Dec 31, 2024 | 24.04% |
| Sep 30, 2024 | 30.42% |
| Jun 30, 2024 | 131.64% |
| Mar 31, 2024 | -25.95% |
| Dec 31, 2023 | -11.01% |
| Sep 30, 2023 | -18.50% |
| Jun 30, 2023 | 85.52% |
| Mar 31, 2023 | -12.18% |
| Dec 31, 2022 | -0.36% |
| Sep 30, 2022 | 9.82% |
| Jun 30, 2022 | -6.83% |
| Mar 31, 2022 | -17.46% |
| Dec 31, 2021 | -4.62% |
| Sep 30, 2021 | 48.62% |
| Jun 30, 2021 | 28.56% |
| Mar 31, 2021 | -38.42% |
| Dec 31, 2020 | 159.72% |
| Sep 30, 2020 | 143.63% |
| Jun 30, 2020 | -36.22% |
| Mar 31, 2020 | -37.09% |
| Dec 31, 2019 | 295.13% |
| Sep 30, 2019 | -44.55% |
| Jun 30, 2019 | -7.92% |
| Mar 31, 2019 | -18.11% |
| Dec 31, 2018 | 59.70% |
| Sep 30, 2018 | -3.82% |
| Jun 30, 2018 | 110.59% |
| Mar 31, 2018 | -40.28% |
| Dec 31, 2017 | -5.76% |
| Sep 30, 2017 | 75.18% |
| Jun 30, 2017 | 51.13% |
| Mar 31, 2017 | -60.92% |
| Dec 31, 2016 | 228.87% |
| Sep 30, 2016 | -47.46% |